Author
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of October 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of September 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of August 2021.
Topics range from issues related to FDA’s approval of aducanumab, to an analysis of the communication of survival data in cancer drug labels.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of June 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of May 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of March 2021.
Patients may face increased out-of-pocket drug costs as a result of a rule finalized by the Centers for Medicare & Medicaid Services in July 2020.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of February 2021.
